Key result
miR-194 overexpression reduces hypertrophic cardiomyocyte area by ~30% via inhibiting CnA/NFATc2 signaling.
Why the study?
This study explored the effects of miR-194 on isoproterenol-induced chronic cardiac hypertrophy and its potential mechanism via the CnA/NFATc2 pathway in rat cardiomyoblast cells.
Does overexpression of miR-194 attenuate isoproterenol-induced cardiomyocyte hypertrophy via targeting the CnA/NFATc2 signaling pathway in H9c2 cells?
Does overexpression of miR-194 attenuate isoproterenol-induced cardiomyocyte hypertrophy via targeting the CnA/NFATc2 signaling pathway in H9c2 cells?
Answers are grounded in this paper and cite their sources.
Preclinical in vitro evidence identifies miR-194 as a negative regulator of isoproterenol-induced cardiomyocyte hypertrophy through direct post-transcriptional inhibition of calcineurin A (CnA) and downstream NFATc2 nuclear translocation.
Background: This study explored the effects of microRNA(miR)-194 on chronic cardiac hypertrophy (CH) induced by isoproterenol (ISO). The potential mechanism through regulation of the calcineurin A (CnA)/nuclear factor of activated T cells (NFAT) c2 pathway was investigated in the rat cardiomyoblast cell line H9c2. Methods: . The cell surface area was assessed by phalloidin staining. The expression of miR-194, CnA mRNA, and CnA protein were assessed. Furthermore, the cellular localization of the NFATc2 protein after induction of CH was detected. The relationship between miR-194 and the CnA mRNA 3'-untranslated region (UTR) was verified by dual luciferase report assays. By constructing cardiomyocyte cell models with low expression of miR-194 and/or CnA, the effects of miR-194 and CnA on the localization of the NFATc2 protein and cell hypertrophy was investigated. Rescue experiments were conducted to analyze whether overexpression of miR-194 could alleviate the cell hypertrophy induced by ISO. Results: The results demonstrated that induction with ISO significantly increased the surface area of H9c2 cells. After induction, the expression of miR-194 decreased, while both CnA mRNA and protein expression increased. Furthermore, the nuclear translocation of NFATc2 was obvious. MiR-194 bound to the 3'-UTR of CnA mRNA and inhibited CnA protein expression. Inhibition of miR-194 expression activated NFATc2 protein expression and increased the H9c2 cell surface area. After CnA expression was disturbed, hypertrophy induced by miR-194 down-regulation was blocked. In addition, overexpression of miR-194 significantly alleviated cell hypertrophy and activation of the CnA/NFATc2 pathway caused by ISO. Conclusions: In conclusion, increasing the expression of miR-194 can alleviate CH by targeting can and inhibiting the CnA/NFATc2 pathway.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) studied Isoproterenol-induced chronic cardiac hypertrophy (in vitro H9c2 rat cardiomyoblast model). miR-194 mimic (overexpression) / miR-194 inhibitor / siCnA transfection vs. Negative control (NC) transfectants and/or isoproterenol-only treated H9c2 cells was evaluated on Cardiomyocyte hypertrophy (H9c2 cell surface area) and CnA/NFATc2 signaling activation (p=<0.05). Overexpression of miR-194 reduced H9c2 cardiomyocyte surface area to about 70% of the isoproterenol-treated area by inhibiting CnA/NFATc2 signaling.
Synapse has enriched 10 related papers. Consider them for comparative context: